Argus downgraded Colgate-Palmolive from Buy to Hold
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/13/2026 | $86.00 | Underweight → Equal Weight | Wells Fargo |
| 1/7/2026 | $88.00 | Neutral → Overweight | Piper Sandler |
| 12/11/2025 | Buy → Hold | Argus | |
| 12/9/2025 | $88.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 10/3/2025 | $84.00 | Neutral | Piper Sandler |
| 10/28/2024 | $105.00 → $101.00 | Buy → Hold | Stifel |
| 9/24/2024 | $121.00 | Overweight | Piper Sandler |
| 9/16/2024 | $100.00 | Equal Weight → Underweight | Wells Fargo |
4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)
4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)
4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)
8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)
CERT - COLGATE PALMOLIVE CO (0000021665) (Filer)
8-A12B - COLGATE PALMOLIVE CO (0000021665) (Filer)
Wells Fargo upgraded Colgate-Palmolive from Underweight to Equal Weight and set a new price target of $86.00
Piper Sandler upgraded Colgate-Palmolive from Neutral to Overweight and set a new price target of $88.00
Argus downgraded Colgate-Palmolive from Buy to Hold
Colgate-Palmolive Company (NYSE:CL): Full Year Net sales and Organic sales* increased 1.4%, including a 0.7% negative impact from lower private label pet volume GAAP EPS declined 25% to $2.63, driven by goodwill and intangible assets impairment charges related to the skin health business Base Business EPS* increased 3% to $3.69 Net cash provided by operations was a record $4,198 for the full year Returned $2.9 billion in cash to shareholders through dividends and share repurchases Full Year Total Company Results (GAAP) ($ in millions except per share amounts) 2025 2024 Change Net Sales $20,382 $20,101 +1.4% EP
Multi-year funding will advance oral health, as oral diseases are among the most prevalent and overlooked noncommunicable diseases impacting 3.7 billion people globally.1 Today, Colgate-Palmolive announced a new multi-year collaboration with the WHO Foundation to support the World Health Organization's work on oral health. The four-year funding commitment will help expand oral health education, support integration of oral health into national health systems, and raise awareness of oral health as a public health priority. This initiative builds on Colgate's commitment to providing communities with oral health education and resources. The Company recently announced that the Colgate Bright S
Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 fourth quarter and full year earnings conference call on Friday, January 30, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-webcasts. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website.
Colgate-Palmolive Company (NYSE:CL): Full Year Net sales and Organic sales* increased 1.4%, including a 0.7% negative impact from lower private label pet volume GAAP EPS declined 25% to $2.63, driven by goodwill and intangible assets impairment charges related to the skin health business Base Business EPS* increased 3% to $3.69 Net cash provided by operations was a record $4,198 for the full year Returned $2.9 billion in cash to shareholders through dividends and share repurchases Full Year Total Company Results (GAAP) ($ in millions except per share amounts) 2025 2024 Change Net Sales $20,382 $20,101 +1.4% EP
Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 fourth quarter and full year earnings conference call on Friday, January 30, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-webcasts. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website.
The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on February 13, 2026, to shareholders of record on January 21, 2026. The Company has paid uninterrupted dividends on its common stock since 1895. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed
The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi
IRVINE, Calif., March 12, 2024 /PRNewswire/ -- ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE:CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.
Colgate-Palmolive Company (NYSE:CL) today announced that its Board of Directors has appointed Lorrie Norrington as Lead Independent Director, effective March 1, 2023. Ms. Norrington will succeed Stephen I. Sadove, the Company's current Lead Independent Director. Mr. Sadove will remain on the Audit and Personnel and Organization Committees of the Colgate Board of Directors. Ms. Norrington joined the Company's Board in September 2015 and currently serves as Chair of the Nominating, Governance and Corporate Responsibility Committee. She brings extensive global corporate leadership, digital, e-commerce and ESG experience to this role, including her experience in several senior management roles
SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)
SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)
SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)